Position in INGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$411,613
+$220,454 QoQ
Shares Held
63,816
+106.3% QoQ
Ownership
0.240%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#42
of 128 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $33,000,533 across 20 Medical Devices names. INGN ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
29,009 | $6,108,425 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
14,056 | $4,126,982 | |
| 3 | ENOV |
Enovis CORP
|
139,970 | $2,897,379 | |
| 4 | HAE |
Haemonetics Corp
|
36,844 | $2,763,300 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
22,024 | $2,619,754 | |
| 6 | ABT |
Abbott Laboratories
|
27,012 | $2,451,068 | |
| 7 | PODD |
Insulet Corp
|
12,102 | $1,842,529 | |
| 8 | EW |
Edwards Lifesciences Corp
|
17,148 | $1,551,208 |
All Filings in INGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,613 | 63,816 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $191,159 | 30,932 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $462,389 | 68,808 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $553,019 | 67,689 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $430,545 | 61,244 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $489,139 | 68,603 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $540,745 | 58,969 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $503,885 | 51,947 | Shares | Sole | 2024-11-12 | |
| 2021-09-30 | $217,906 | 5,057 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||